MoneyWorks4Me

Gufic Biosciences - Quaterly Results

11 Nov 2022 Evaluate
The sales slipped to Rs. 1748.35 millions for the September 2022 quarter as against Rs. 1941.39 millions during the year-ago period.Net profit declined -13.38% to Rs. 202.12 millions from Rs. 233.35 millions.Operating profit for the quarter ended September 2022 decreased to 334.31 millions as compared to 361.34 millions of corresponding quarter ended September 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 1748.35 1941.39 -9.94 3401.11 4448.97 -23.55 7791.56 4876.99 59.76
Other Income 8.18 3.05 168.20 11.93 15.33 -22.18 31.04 37.33 -16.85
PBIDT 334.31 361.34 -7.48 669.85 830.10 -19.30 1488.20 876.53 69.78
Interest 16.06 15.49 3.68 25.14 27.58 -8.85 48.47 136.33 -64.45
PBDT 318.25 345.85 -7.98 644.71 802.52 -19.66 1439.73 740.20 94.51
Depreciation 45.64 41.97 8.74 89.29 83.23 7.28 171.34 163.08 5.06
PBT 272.61 303.88 -10.29 555.42 719.29 -22.78 1268.39 577.12 119.78
TAX 70.49 70.53 -0.06 142.78 173.87 -17.88 309.98 134.80 129.96
Deferred Tax -6.51 -6.17 5.51 -7.82 -8.43 -7.24 -11.52 20.11 -157.28
PAT 202.12 233.35 -13.38 412.64 545.42 -24.34 958.41 442.32 116.68
Equity 96.94 96.94 0.00 96.94 96.95 -0.01 96.94 96.94 0.00
PBIDTM(%) 19.12 18.61 2.74 19.70 18.66 5.56 19.10 17.97 6.27
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..